Results 251 to 260 of about 1,679,247 (398)

Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis. [PDF]

open access: bronze, 1993
Guido Basilisco   +4 more
openalex   +1 more source

Continuous Intravenous Nimodipine Infusion With Ethanol as Carrier in Aneurysmal Subarachnoid Hemorrhage Does Not Result in Measurable Cerebral Ethanol Levels

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
An unimpaired neurological evaluation is essential for detecting delayed cerebral ischemia (DCI) in aneurysmal subarachnoid hemorrhage (aSAH) patients. Nimodipine is currently the only drug approved for DCI prevention. Intravenous nimodipine infusion contains 23.7 vol% ethanol as an excipient, resulting in up to 45 g of ethanol being infused daily ...
Miriam M. Moser   +8 more
wiley   +1 more source

Macrophage Activation in Systemic Sclerosis. [PDF]

open access: yesJACC Basic Transl Sci
Turco MC   +5 more
europepmc   +1 more source

Gender-related differences in systemic sclerosis.

open access: yesAutoimmunity Reviews, 2020
M. Hughes   +5 more
semanticscholar   +1 more source

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

open access: yesESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher   +3 more
wiley   +1 more source

A CASE OF PROGRESSIVE SYSTEMIC SCLEROSIS COMPLICATED WITH ESOPHAGEAL VARIX

open access: bronze, 1985
Heiichiro TAJIMA   +9 more
openalex   +2 more sources

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy